Skip to main content

Epilepsy and cannabis in Massachusetts

The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Physician-discretion program
✗ No
LEGAL
10 oz usable (60-day su…
POSSESSION
$50/yr
STATE FEE
7–21 d
TIMELINE
Physician-discretion program. The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Massachusetts statute and program

The Massachusetts Medical Use of Marijuana Program is the operating authority for Massachusetts patient certification. The authoritative legal text is: M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribed. The program portal is at Massachusetts Medical Use of Marijuana Program.

What the evidence says about cannabis and Epilepsy

Epilepsy is a chronic neurological disorder defined by recurrent unprovoked seizures. The condition affects an estimated 3.4 million Americans. Most patients respond to anti-seizure medications, but approximately one-third develop treatment-resistant epilepsy that fails two or more first-line drugs.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Epilepsy page.

How to qualify in Massachusetts

The Massachusetts Medical Use of Marijuana Program requires the following registration steps for a Epilepsy patient (or any qualifying diagnosis):

  1. Get certified by a Massachusetts-licensed certifying healthcare provider. A Massachusetts-licensed physician, certified nurse practitioner, or physician assistant registered with the Cannabis Control Commission (CCC) Medical Use of Marijuana Program must establish a bona-fide provider-patient relationship and certify a debilitating condition. CCC regulations allow providers to certify enumerated conditions (cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s, Parkinson’s, MS) plus "other conditions determined by a qualifying provider" — broad practitioner discretion.
  2. Complete the online patient registration via Virtual Gateway. After certification, the provider creates a Virtual Gateway PIN that the patient uses to complete the online registration through the Massachusetts Cannabis Control Commission MMJ Online System. Patients upload a Massachusetts driver license or state ID and a passport-style photo.
  3. Pay the $50 state fee (or qualify for fee waiver). The annual program registration fee is $50, waived for veterans, low-income patients (verified through MassHealth, SNAP, SSI, SSDI, or Veterans Affairs benefits documentation), and hospice patients. Temporary patient registration cards are emailed within several business days of approval; physical cards arrive within roughly two to three weeks.
  4. Purchase from a Massachusetts medical marijuana treatment center. With the temporary or physical card, patients may purchase up to a 60-day supply (default 10 ounces) from any of the licensed Massachusetts Medical Marijuana Treatment Centers. Adult-use retail exists statewide for adults 21+, but the medical registration provides access to medical-only products, no excise tax, higher possession limits, and family-court and workplace protections under M.G.L. c. 94I.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
7–21 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Massachusetts registration steps, fees, and reciprocity rules, see the Massachusetts cannabis-laws page.

ICD-10 code

A certifying physician documenting Epilepsy for the Massachusetts medical cannabis program will typically record ICD-10 G40.909 or SNOMED-CT 84757009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Massachusetts list Epilepsy as a qualifying condition for medical cannabis?

Not by name, but Massachusetts permits physician discretion. Under Massachusetts Medical Use of Marijuana Program, a certifying physician can add a condition like Epilepsy on a case-by-case basis when the physician judges that the patient would benefit from medical cannabis. This is different from a state where the qualifying-condition list is fixed in statute. Whether a particular physician will certify Epilepsy depends on the physician's training, the strength of the patient's documentation, and the practitioner's reading of the available evidence — evidence is described as strong (e.g. multiple randomized controlled trials or systematic reviews supporting effect). Patients should expect to bring full diagnostic records to the certification visit.

How do I get a Massachusetts medical marijuana card for Epilepsy?

Step one is finding a physician licensed in Massachusetts who is registered with Massachusetts Medical Use of Marijuana Program and willing to evaluate Epilepsy cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Massachusetts does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Massachusetts Medical Use of Marijuana Program site at https://masscannabiscontrol.com/medical-use/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Epilepsy?

For Epilepsy, evidence is described as strong (e.g. multiple randomized controlled trials or systematic reviews supporting effect). The mmjnow condition page for Epilepsy lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Epilepsy should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Epilepsy and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Epilepsy; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribedaccessed May 16, 2026
  2. M.G.L. Chapter 94I: Medical Use of Marijuanaaccessed May 16, 2026
  3. Massachusetts Cannabis Control Commissionaccessed May 16, 2026
  4. Question 4 of 2016: Regulation and Taxation of Marijuana Act (Ballotpedia)accessed May 16, 2026
  5. NORML: Massachusetts Laws & Penaltiesaccessed May 16, 2026
  6. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026

    “Conclusive or substantial evidence that oral cannabidiol is effective for the treatment of certain epilepsy syndromes.”

  7. FDA: Epidiolex (cannabidiol) prescribing informationaccessed May 15, 2026
  8. NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 15, 2026